Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

New Human Hybrid IgM Control Monoclonal Antibody

Characterized disease state sera are serum samples derived from individuals with specific medical conditions or diseases. These sera are valuable in many aspects of diagnostics, particularly in the development and validation testing of diagnostic assays. They are used as optimization tools, calibration standards, reference materials, and quality control tools.

Characterized disease state sera help ensure that diagnostic tests can reliably and accurately identify individuals with particular medical conditions by meeting regulatory parameters such as sensitivity, reproducibility, and precision. However, sourcing these sera can be complicated, time-consuming, and sometimes suitable material may not be available. Especially IgM sera, during the immune response, IgM levels are dynamic. Similarly, each disease type brings unique changes in IgM levels and characteristics, meaning prior expert knowledge is necessary.

To overcome these debilitating problems, Creative Diagnostics has an alternative to the hard-to-find human disease state IgM plasma. These Human hybrid IgM control Mab materials cover many diseases, including CMV, HSV, MeV, MuV, RuV, M. pneumoniae, T. gondii, and VZV.

The diagnostic potential of characterized disease state serum and plasma derived from the centrifugation of bloodFig. 1 The diagnostic potential of characterized disease state serum and plasma derived from the centrifugation of blood.

How to Produce

These monoclonal antibodies have been produced in mice genetically modified to express human IgM heavy chain constant region. They are then concentrated and spiked into an IgG depleted and delipidised human serum matrix which ensures that the final product is as close as possible to the natural disease state IgM positive human plasma. Testing in both ELISA and bead-based applications shows the products behave in an almost identical manner to the natural source.

Product Features

  • Lot-to-lot consistency
  • Reliable source
  • ISO 13485 production
  • Highly specific

Our Hybrid IgM Monoclonal Antibodies have been shown to perform comparably to natural serum. They remove concerns about availability or quality, and ensure a high-quality, reproducible product. Should you require more information, please do not hesitate to contact us.

<
Cat. No.Product NameIsotypeApplication
DMAB-CLS25048Human Anti-CMV Mab, clone 2499IgMControlInquiry
DMAB-CLS25049Human Anti-HSV-1/2 Mab, clone 2406IgMControlInquiry
DMAB-CLS25050Human Anti-Measles Virus Mab, clone 2400IgMControlInquiry
DMAB-CLS25051Human Anti-Mump viurs Mab, clone 2512IgMControlInquiry
DMAB-CLS25052Human Anti-M. pneumoniae Mab, clone 2523IgMControlInquiry
DMAB-CLS25053Human Anti-Rubella Virus Mab, clone 2472IgMControlInquiry
DMAB-CLS25054Human Anti-T. gondii Mab, clone 2515IgMControlInquiry
DMAB-CLS25055Human Anti-VZV Mab, clone 2518IgMControlInquiry
Inquiry Basket
loading Loading ......

Inquiry

Inquiry